MedKoo Cat#: 408176 | Name: SG-094
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SG-094 is a TPC2 inhibitor. SG-094 exhibits anti-tumor effects with potential translational relevance.

Chemical Structure

SG-094
CAS#2922283-37-0

Theoretical Analysis

MedKoo Cat#: 408176

Name: SG-094

CAS#: 2922283-37-0

Chemical Formula: C30H29NO3

Exact Mass: 451.2147

Molecular Weight: 451.57

Elemental Analysis: C, 79.80; H, 6.47; N, 3.10; O, 10.63

Price and Availability

Size Price Availability Quantity
100mg USD 1,250.00 2 Weeks
200mg USD 1,950.00 2 Weeks
500mg USD 2,950.00 2 Weeks
1g USD 3,950.00 2 Weeks
2g USD 6,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SG-094; SG 094; SG094
IUPAC/Chemical Name
6-methoxy-2-methyl-7-phenoxy-1-(4-phenoxybenzyl)-1,2,3,4-tetrahydroisoquinoline
InChi Key
BTNHPUSFPKFAPU-UHFFFAOYSA-N
InChi Code
InChI=1S/C30H29NO3/c1-31-18-17-23-20-29(32-2)30(34-25-11-7-4-8-12-25)21-27(23)28(31)19-22-13-15-26(16-14-22)33-24-9-5-3-6-10-24/h3-16,20-21,28H,17-19H2,1-2H3
SMILES Code
CN1C(CC2=CC=C(OC3=CC=CC=C3)C=C2)C4=CC(OC5=CC=CC=C5)=C(OC)C=C4CC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 451.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Alharbi AF, Parrington J. TPC2 targeting evolution: Leveraging therapeutic opportunities for cancer. Cell Chem Biol. 2021 Aug 19;28(8):1103-1105. doi: 10.1016/j.chembiol.2021.07.020. PMID: 34416140. Chi G, Jaślan D, Kudrina V, Böck J, Li H, Pike ACW, Rautenberg S, Krogsaeter E, Bohstedt T, Wang D, McKinley G, Fernandez-Cid A, Mukhopadhyay SMM, Burgess-Brown NA, Keller M, Bracher F, Grimm C, Dürr KL. Structural basis for inhibition of the lysosomal two-pore channel TPC2 by a small molecule antagonist. Structure. 2024 Aug 8;32(8):1137-1149.e4. doi: 10.1016/j.str.2024.05.005. Epub 2024 May 29. PMID: 38815576. Shimomura T. Descending to inhibit: Antagonist-induced downward shift of VSD II in TPC2. Structure. 2024 Aug 8;32(8):1025-1027. doi: 10.1016/j.str.2024.07.005. PMID: 39121835.